Literature DB >> 7607692

Assignment of the XRCC2 human DNA repair gene to chromosome 7q36 by complementation analysis.

N J Jones1, Y Zhao, M J Siciliano, L H Thompson.   

Abstract

The V79 hamster cell line irs1 is a repair-deficient mutant hypersensitive to radiation and DNA-reactive chemical agents. Somatic cell hybrids were formed by fusing irs1 cells with human lymphocytes and selecting for complementation in medium containing concentrations of mitomycin C (MMC) that are toxic to irs1. Thirty-eight MMC-resistant hybrids showed extensive segregation of human chromosomes, with 35 of them retaining human chromosome 7, as indicated by molecular marker and cytogenetic analyses. Inter-Alu-PCR products from the DNA of hybrids, when used as fluorescence in situ hybridization probe onto normal human metaphases, indicated that one resistant hybrid was monochromosomal for chromosome 7 and that the three resistant hybrids shown to be negative for chromosome 7 markers have retained portions of chromosome 7, with region 7q36 being the smallest common region. MMC-sensitive subclones of a resistant hybrid lost human chromosome 7. Therefore, the gene complementing the repair defect, XRCC2 (X-ray repair cross complementing), is assigned to human chromosome 7q36.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607692     DOI: 10.1016/0888-7543(95)80187-q

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Suppression of retroviral infection by the RAD52 DNA repair protein.

Authors:  Alan Lau; Roland Kanaar; Stephen P Jackson; Mark J O'Connor
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Isolation of novel human and mouse genes of the recA/RAD51 recombination-repair gene family.

Authors:  R Cartwright; A M Dunn; P J Simpson; C E Tambini; J Thacker
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  Region and amino acid residues required for Rad51C binding in the human Xrcc3 protein.

Authors:  Hitoshi Kurumizaka; Rima Enomoto; Maki Nakada; Keiko Eda; Shigeyuki Yokoyama; Takehiko Shibata
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 4.  Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.

Authors:  Sharon A Savage; Michael F Walsh
Journal:  Hematol Oncol Clin North Am       Date:  2018-08       Impact factor: 3.722

5.  XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor.

Authors:  Kaiwu Xu; Xinming Song; Zhihui Chen; Changjiang Qin; Yulong He
Journal:  Oncol Lett       Date:  2014-06-11       Impact factor: 2.967

6.  XRCC2 promotes colorectal cancer cell growth, regulates cell cycle progression, and apoptosis.

Authors:  Kaiwu Xu; Xinming Song; Zhihui Chen; Changjiang Qin; Yulong He; Wenhua Zhan
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

7.  miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.

Authors:  Kaiwu Xu; Zhihui Chen; Changjiang Qin; Xinming Song
Journal:  Onco Targets Ther       Date:  2014-02-20       Impact factor: 4.147

8.  XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer.

Authors:  Lijie Wang; Junxun Ma; Bo Yang; Fangfang Jing; Yi Hu
Journal:  Med Sci Monit       Date:  2018-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.